Patent ID: 6290947
Filing Date: 2001-09-18
Classification: A61K,Y02A

Abstract:
A method for inhibiting a pathogenic toxin in a mammal, comprising the step of orally administering to the mammal a therapeutically effective amount of a polymer characterized by a repeat unit of comprising a plurality of Formula I, ##STR6##wherein R is a hydrogen atom or a methyl or ethyl group; X is a covalent bond, a carbonyl group or a CH.sub.2 group; Y is an oxygen atom or an NH or CH.sub.2 group; Z is an aliphatic spacer group; R.sup.1, R.sup.2 and R.sup.3 are each, independently, a hydrogen atom, a normal or branched, substituted or unsubstituted C.sub.1 -C.sub.24 -alkyl group, aryl or arylalkyl group; and m and n are each, independently, 1 or 0; or --N.sup.+ (R.sup.1)(R.sup.2)(R.sup.3) is a heteroaryl group; and A.sup.- is a pharmaceutically acceptable anion; or a free base thereof.